# US 2021/0155894 A1 · Genome-wide rationally-designed mutations leading to enhanced lysine production in e. coli

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2021/0155894 A1
- Document ID: US20210155894A1
- Status: Published application
- Kind: A1
- Application number: 17/159,137
- Filed: 2021-01-26
- Published: 2021-05-27
- Earliest claimed: 2019-06-21
- Assignees: Inscripta, Inc.
- Applicants: Inscripta, Inc.
- Inventors: Richard Fox; Daniel Held; Eric Abbate; Michael Clay; Katherine Krouse; Nandini Krishnamurthy; Krishna Yerramsetty
- Web page: https://patentgrep.com/patent/US20210155894A1

## CPC

- C12N 1/20: Bacteria; Culture media therefor
- C12P 13/08: Lysine; Diaminopimelic acid; Threonine; Valine
- C07K 14/245: Escherichia (G)
- C12N 9/0006: {acting on CH-OH groups as donors (1.1)}
- C12N 9/1217: {Phosphotransferases with a carboxyl group as acceptor (2.7.2)}
- C12N 9/1241: {Nucleotidyltransferases (2.7.7)}
- C12N 9/16: acting on ester bonds (3.1)
- C12N 9/2417: {from microbiological source}
- C12N 9/88: Lyases (4.)
- C12N 15/52: Genes encoding for enzymes or proenzymes
- C12Y 101/01003: Homoserine dehydrogenase (1.1.1.3)
- C12Y 101/0104: Malate dehydrogenase (oxaloacetate-decarboxylating) (NADP+) (1.1.1.40)
- C12Y 207/02004: Aspartate kinase (2.7.2.4)
- C12Y 207/07004: Sulfate adenylyltransferase (2.7.7.4)
- C12Y 207/07042: [Glutamate--ammonia-ligase] adenylyltransferase (2.7.7.42)
- C12Y 207/07059: [Protein-PII] uridylyltransferase (2.7.7.59)
- C12Y 301/04052: Cyclic-guanylate-specific phosphodiesterase (3.1.4.52)
- C12Y 302/01001: Alpha-amylase (3.2.1.1)
- C12Y 401/01049: Phosphoenolpyruvate carboxykinase (ATP) (4.1.1.49)
- C12Y 402/01042: Galactarate dehydratase (4.2.1.42)
- C12Y 402/03003: Methylglyoxal synthase (4.2.3.3)
- C12Y 403/03007: 4-Hydroxy-tetrahydrodipicolinate synthase (4.3.3.7)
- C12N 2510/02: Cells for production
- C12N 2511/00: Cells for large scale production
- C12R 2001/19: Escherichia coli
- C12N: MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media C12Q1/00)
- C12P: FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE {(brewing of beer C12C; producing vinegar C12J; producing specific peptides or proteins C07K; producing enzymes C12N9/00; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification C12N15/00; measuring or testing processes involving enzymes or microorganisms C12Q; measuring or testing processes involving nucleic acid amplification reactions C12Q1/6844; fermentation processes to form a food composition, A21 or A23; compounds in general, see the relevant compound class, e.g. C01, C07)}
- C07K: PEPTIDES (peptides in foodstuffs A23; obtaining protein compositions for foodstuffs, working-up proteins for foodstuffs A23J; preparations for medicinal purposes A61K; peptides containing beta-lactam rings C07D; cyclic dipeptides not having in their molecule any other peptide link than those which form their ring, e.g. piperazine-2,5-diones, C07D; ergot alkaloids of the cyclic peptide type C07D519/02; macromolecular compounds having statistically distributed amino acid units in their molecules, i.e. when the preparation does not provide for a specific; but for a random sequence of the amino acid units, homopolyamides and block copolyamides derived from amino acids C08G69/00; macromolecular products derived from proteins C08H1/00; preparation of glue or gelatine C09H; single cell proteins, enzymes C12N; genetic engineering processes for obtaining peptides C12N15/00; compositions for measuring or testing processes involving enzymes C12Q; investigation or analysis of biological material G01N33/00)
- C12Y: ENZYMES
- C12R: INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS

## Abstract

The present disclosure relates to various different types of variants in E. coli coding and noncoding regions leading to enhanced lysine production for, e.g., supplements and nutraceuticals.

## Claims

### Claim 1

An engineered E. coli cell comprising the following variant sequences: a promoter sequence having the nucleic acid SEQ ID No. 2 driving transcription of a dapA gene, and further comprising one of the following proteins: a mfdY5 protein having the amino acid sequence of SEQ ID No. 21, a nupXR5 protein having the amino acid sequence of SEQ ID No. 22, a pck protein having the amino acid sequence of SEQ ID No. 23, a phoB protein encoded by the nucleic acid sequence of SEQ ID No. 24, a purM protein encoded by the nucleic acid sequence of SEQ ID No. 25, a rlmL protein having the amino acid sequence of SEQ ID No. 26, a wzxB protein having the amino acid sequence of SEQ ID No. 27, a ydgl protein encoded by the nucleic acid sequence of SEQ ID No. 28, a ydjE protein encoded by the nucleic acid sequence of SEQ ID No. 29, a yicL protein coding sequence encoded by the nucleic acid sequence of SEQ ID No. 30, a yliE protein encoded by the nucleic acid sequence of SEQ ID No. 31, a yohF protein encoded by the nucleic acid sequence of SEQ ID No. 32, a ytfP protein having the amino acid sequence of SEQ ID No. 33, a marA protein having the amino acid sequence of SEQ ID No. 34, a marA protein having the amino acid sequence of SEQ ID No. 35, a metL protein having the amino acid sequence of SEQ ID No. 36, a metL protein having the amino acid sequence of SEQ ID No. 37, a pck protein having the amino acid sequence of SEQ ID No. 38, a setB protein encoded by the nucleic acid sequence of SEQ ID No. 39, a ydfO protein encoded by the nucleic acid sequence of SEQ ID No. 40, a ydgD protein encoded by the nucleic acid sequence of SEQ ID No. 41, or a yejG protein encoded by the nucleic acid sequence of SEQ ID No. 42.

### Claim 2 (depends on 1)

The engineered E. coli cell of claim 1 comprising the promoter sequence having the nucleic acid SEQ ID No. 2 driving transcription of the dapA gene and further comprising the mfdY5 protein having the amino acid sequence of SEQ ID No. 21.

### Claim 3 (depends on 1)

The engineered E. coli cell of claim 1 comprising the promoter sequence having the nucleic acid SEQ ID No. 2 driving transcription of the dapA gene and further comprising the nupXR5 protein having the amino acid sequence of SEQ ID No. 22.

### Claim 4 (depends on 1)

The engineered E. coli cell of claim 1 comprising the promoter sequence having the nucleic acid SEQ ID No. 2 driving transcription of the dapA gene and further comprising the pck protein having the amino acid sequence of SEQ ID No. 23.

### Claim 5 (depends on 1)

The engineered E. coli cell of claim 1 comprising the promoter sequence having the nucleic acid SEQ ID No. 2 driving transcription of the dapA gene and further comprising the phoB protein encoded by the nucleic acid sequence of SEQ ID No. 24.

### Claim 6 (depends on 1)

The engineered E. coli cell of claim 1 comprising the promoter sequence having the nucleic acid SEQ ID No. 2 driving transcription of the dapA gene and further comprising the purM protein encoded by the nucleic acid sequence of SEQ ID No. 25.

### Claim 7 (depends on 1)

The engineered E. coli cell of claim 1 comprising the promoter sequence having the nucleic acid SEQ ID No. 2 driving transcription of the dapA gene and further comprising the rlmL protein having the amino acid sequence of SEQ ID No. 26.

### Claim 8 (depends on 1)

The engineered E. coli cell of claim 1 comprising the promoter sequence having the nucleic acid SEQ ID No. 2 driving transcription of the dapA gene and further comprising the wzxB protein having the amino acid sequence of SEQ ID No. 27.

### Claim 9 (depends on 1)

The engineered E. coli cell of claim 1 comprising the promoter sequence having the nucleic acid SEQ ID No. 2 driving transcription of the dapA gene and further comprising the ydgl protein encoded by the nucleic acid sequence of SEQ ID No. 28.

### Claim 10 (depends on 1)

The engineered E. coli cell of claim 1 comprising the promoter sequence having the nucleic acid SEQ ID No. 2 driving transcription of the dapA gene and further comprising the ydjE protein encoded by the nucleic acid sequence of SEQ ID No. 29.

### Claim 11 (depends on 1)

The engineered E. coli cell of claim 1 comprising the promoter sequence having the nucleic acid SEQ ID No. 2 driving transcription of the dapA gene and further comprising the yicL protein coding sequence encoded by the nucleic acid sequence of SEQ ID No. 30.

### Claim 12 (depends on 1)

The engineered E. coli cell of claim 1 comprising the promoter sequence having the nucleic acid SEQ ID No. 2 driving transcription of the dapA gene and further comprising the yliE protein encoded by the nucleic acid sequence of SEQ ID No. 31.

### Claim 13 (depends on 1)

The engineered E. coli cell of claim 1 comprising the promoter sequence having the nucleic acid SEQ ID No. 2 driving transcription of the dapA gene and further comprising the yohF protein encoded by the nucleic acid sequence of SEQ ID No. 32.

### Claim 14 (depends on 1)

The engineered E. coli cell of claim 1 comprising the promoter sequence having the nucleic acid SEQ ID No. 2 driving transcription of the dapA gene and further comprising the ytfP protein having the amino acid sequence of SEQ ID No. 33.

### Claim 15 (depends on 1)

The engineered E. coli cell of claim 1 comprising the promoter sequence having the nucleic acid SEQ ID No. 2 driving transcription of the dapA gene and further comprising the marA protein having the amino acid sequence of SEQ ID No. 34.

### Claim 16 (depends on 1)

The engineered E. coli cell of claim 1 comprising the promoter sequence having the nucleic acid SEQ ID No. 2 driving transcription of the dapA gene and further comprising the marA protein having the amino acid sequence of SEQ ID No. 35.

### Claim 17 (depends on 1)

The engineered E. coli cell of claim 1 comprising the promoter sequence having the nucleic acid SEQ ID No. 2 driving transcription of the dapA gene and further comprising the metL protein having the amino acid sequence of SEQ ID No. 36.

### Claim 18 (depends on 1)

The engineered E. coli cell of claim 1 comprising the promoter sequence having the nucleic acid SEQ ID No. 2 driving transcription of the dapA gene and further comprising the a metL protein having the amino acid sequence of SEQ ID No. 37.

### Claim 19 (depends on 1)

The engineered E. coli cell of claim 1 comprising the promoter sequence having the nucleic acid SEQ ID No. 2 driving transcription of the dapA gene and further comprising the pck protein having the amino acid sequence of SEQ ID No. 38.

### Claim 20 (depends on 1)

The engineered E. coli cell of claim 1 comprising the promoter sequence having the nucleic acid SEQ ID No. 2 driving transcription of the dapA gene and further comprising the setB protein encoded by the nucleic acid sequence of SEQ ID No. 39.

### Claim 21 (depends on 1)

The engineered E. coli cell of claim 1 comprising the promoter sequence having the nucleic acid SEQ ID No. 2 driving transcription of the dapA gene and further comprising the ydfO protein encoded by the nucleic acid sequence of SEQ ID No. 40.

### Claim 22 (depends on 1)

The engineered E. coli cell of claim 1 comprising the promoter sequence having the nucleic acid SEQ ID No. 2 driving transcription of the dapA gene and further comprising the ydgD protein encoded by the nucleic acid sequence of SEQ ID No. 41.

### Claim 23 (depends on 1)

The engineered E. coli cell of claim 1 comprising the promoter sequence having the nucleic acid SEQ ID No. 2 driving transcription of the dapA gene and further comprising the yejG protein encoded by the nucleic acid sequence of SEQ ID No. 42.
